Identifying MGD in Young Patients - Takeaways - MDSpire

Identifying MGD in Young Patients

Digital device use, lifestyle factors, and modern beauty practices affect the growing rate of dry eye in pediatric patients.

  • By

  • Sarah Fackler, managing editor, Optometric Management

  • January 1, 2026

  • 5 min

Share

  • 1

    Meibomian gland dysfunction (MGD) affects 5.5% to 23% of the pediatric population in the U.S., with significant atrophy and tortuosity observed in affected children.

  • 2

    Digital device use over 2-3 hours daily significantly contributes to ocular surface changes and dry eye symptoms in young patients.

  • 3

    Adolescent girls and college-aged women frequently use multiple personal care products, increasing exposure to harmful ingredients linked to dry eye severity.

  • 4

    A structured clinical protocol for early screening and age-appropriate diagnostic testing is essential for effective MGD management in younger populations.

  • 5

    Successful dry eye management requires consistent protocols, patient education, and accessibility to treatment options for younger patients.

Original Source(s)

Identifying MGD in Young Patients

  • by Sarah Fackler, managing editor, Optometric Management

  • January 1, 2026

Related Content

Between the Snapshots: The Case for Continuous Engagement

Taking care of eye patients between visits

Dry Eye Partnership Celebrates 5 Years

Optometric Management spoke with Alcon and the World Council of Optometry (WCO) on the 5-year partnership that is still going strong between the companies, dry eye and patient quality of life, and initiatives in developing resources.

Study Provides Real-World Evidence for Inflammatory DED

Carolina L. Mercado, MD, and colleagues presented data from the American Academy of Ophthalmology IRIS (Intelligent Research in Sight) Registry linked to pharmacy claims data sourced from the Komodo Health Research Dataset.